Viewing Study NCT01276405


Ignite Creation Date: 2025-12-25 @ 3:11 AM
Ignite Modification Date: 2025-12-26 @ 1:49 AM
Study NCT ID: NCT01276405
Status: TERMINATED
Last Update Posted: 2016-11-02
First Post: 2011-01-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: An Observational Study of Xeloda (Capecitabine) Monotherapy in Patients With Colorectal Cancer (AXEL)
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module